Reading and erasing of histone crotonyllysine mimics by the AF9 YEATS domain and SIRT2 deacylase

IF 3.3 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Bioorganic & Medicinal Chemistry Pub Date : 2023-10-12 DOI:10.1016/j.bmc.2023.117500
Nurgül Bilgin, Vildan A. Türkmen, Nesrin Hammami, Nadja R. Christensen, Jordi C.J. Hintzen, Jasmin Mecinović
{"title":"Reading and erasing of histone crotonyllysine mimics by the AF9 YEATS domain and SIRT2 deacylase","authors":"Nurgül Bilgin,&nbsp;Vildan A. Türkmen,&nbsp;Nesrin Hammami,&nbsp;Nadja R. Christensen,&nbsp;Jordi C.J. Hintzen,&nbsp;Jasmin Mecinović","doi":"10.1016/j.bmc.2023.117500","DOIUrl":null,"url":null,"abstract":"<div><p>Lysine acylations on histones and their recognition by chromatin-binding reader domains and removal by histone deacylases function as an important mechanism for eukaryotic gene regulation. Histone lysine crotonylation (Kcr) is an epigenetic mark associated with active transcription, and its installation and removal are dynamically regulated by cellular epigenetic enzymes. Here, we report binding studies and enzyme assays with histone H3K9 peptides bearing simplest Kcr analogs with varying hydrocarbon chain length, bulkiness, rigidity and polarity. We demonstrate that the AF9 YEATS domain displays selectivity for binding of different acylation modifications on histone H3K9 peptides and exhibits preference for bulkier cinnamoylated lysine over crotonylated lysine and its mimics. SIRT2 shows deacylase activity against most of acylated H3K9 peptides bearing different crotonyllysine mimics, however, it displays a poor ability for the removal of cinnamoyl and trifluorocrotonyl groups. These results demonstrate different substrate selectivities of epigenetic proteins acting on crotonyllysine and pave the way for rational design and development of AF9 YEATS and SIRT2 inhibitors for treatment of human diseases, including cancer.</p></div>","PeriodicalId":255,"journal":{"name":"Bioorganic & Medicinal Chemistry","volume":"95 ","pages":"Article 117500"},"PeriodicalIF":3.3000,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0968089623003486/pdfft?md5=912d9bc984b648de18cc63d7c2902cb4&pid=1-s2.0-S0968089623003486-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968089623003486","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Lysine acylations on histones and their recognition by chromatin-binding reader domains and removal by histone deacylases function as an important mechanism for eukaryotic gene regulation. Histone lysine crotonylation (Kcr) is an epigenetic mark associated with active transcription, and its installation and removal are dynamically regulated by cellular epigenetic enzymes. Here, we report binding studies and enzyme assays with histone H3K9 peptides bearing simplest Kcr analogs with varying hydrocarbon chain length, bulkiness, rigidity and polarity. We demonstrate that the AF9 YEATS domain displays selectivity for binding of different acylation modifications on histone H3K9 peptides and exhibits preference for bulkier cinnamoylated lysine over crotonylated lysine and its mimics. SIRT2 shows deacylase activity against most of acylated H3K9 peptides bearing different crotonyllysine mimics, however, it displays a poor ability for the removal of cinnamoyl and trifluorocrotonyl groups. These results demonstrate different substrate selectivities of epigenetic proteins acting on crotonyllysine and pave the way for rational design and development of AF9 YEATS and SIRT2 inhibitors for treatment of human diseases, including cancer.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过AF9 YEATS结构域和SIRT2脱酰酶读取和擦除组蛋白巴豆酰赖氨酸模拟物。
组蛋白上的赖氨酸酰化及其通过染色质结合阅读结构域的识别和通过组蛋白脱酰酶的去除是真核基因调控的重要机制。组蛋白赖氨酸巴豆酰化(Kcr)是一种与活性转录相关的表观遗传标记,其安装和去除受到细胞表观遗传酶的动态调节。在这里,我们报道了组蛋白H3K9肽的结合研究和酶分析,这些肽携带最简单的Kcr类似物,具有不同的烃链长度、体积、刚性和极性。我们证明,AF9-YEATS结构域对组蛋白H3K9肽上不同酰化修饰的结合表现出选择性,并且表现出对体积较大的肉桂酰化赖氨酸比对巴豆酰化赖赖氨酸及其模拟物的偏好。SIRT2对大多数带有不同巴豆赖氨酸模拟物的酰化H3K9肽显示出脱酰酶活性,然而,它对肉桂酰基和三氟巴豆酰基的去除能力较差。这些结果证明了作用于巴豆赖氨酸的表观遗传蛋白的不同底物选择性,并为合理设计和开发用于治疗人类疾病(包括癌症)的AF9 YEATS和SIRT2抑制剂铺平了道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Bioorganic & Medicinal Chemistry
Bioorganic & Medicinal Chemistry 医学-生化与分子生物学
CiteScore
6.80
自引率
2.90%
发文量
413
审稿时长
17 days
期刊介绍: Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.
期刊最新文献
Esterase-responsive nanoparticles (ERN): A targeted approach for drug/gene delivery exploits Recent progress on small molecule TLR4 antagonist against triple-negative breast cancer progression and complications. Graphical abstract TOC Graphical abstract TOC Contents continued
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1